The Patent Finder

Dynavax Technologies Corporation

28 patents currently held · Updated Nov 16, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

2
Ending by 2030
Oct 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 11 to 27, 2026 · next Dec 11
  • 1 fee due Jan 16, 2027
    The maintenance fee for Linear chimeric compounds and methods of use thereof (US 10,350,290) comes due Jan 16, 2027. Unpaid by Jul 16, 2027, it lapses early.
  • 1 fee due Feb 6, 2027
    The maintenance fee for Administration of Polynucleotide Toll-Like Receptor 9 Agonists for Treating Cancer (US 10,369,168) comes due Feb 6, 2027. Unpaid by Aug 6, 2027, it lapses early.
  • 1 fee due May 28, 2027
    The maintenance fee for Toll-like receptor antagonist compounds and methods of use (US 11,827,641) comes due May 28, 2027. Unpaid by Nov 29, 2027, it lapses early.
  • 1 fee due Jul 5, 2027
    The maintenance fee for Human toll-like receptor inhibitors and methods of use thereof (US 9,228,184) comes due Jul 5, 2027. Unpaid by Jan 5, 2028, it lapses early.
  • 1 fee due Aug 4, 2027
    The maintenance fee for Branched chimeric compounds, and methods of use thereof (US 10,548,975) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
  • 1 fee due Oct 14, 2027
    The maintenance fee for Alkyl Chain Modified Imidazoquinoline TLR7/8 Agonist Compounds and Uses Thereof (US 10,618,896) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.
  • 1 fee due Nov 14, 2027
    The maintenance fee for Alkyl Chain Modified Imidazoquinoline TLR7/8 Agonist Compounds and Uses Thereof (US 11,981,670) comes due Nov 14, 2027. Unpaid by May 15, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,476,053Methods and compositions for inhibition of immune responses and autoimmunity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,962,579Methods and compositions for inhibition of immune responses and autoimmunity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,940,310Methods of treatment using TLR7 and/or TLR9 inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,347,064Methods of treatment using TLR7 and/or TLR9 inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,452,212Methods and compositions for eliciting an immune response against hepatitis B virus
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,884,110Methods and compositions for eliciting an immune response against hepatitis B virus
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,314,907Methods and compositions for eliciting an immune response against hepatitis B virus
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,228,184Human toll-like receptor inhibitors and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,868,955Human toll-like receptor inhibitors and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,950,064Branched and linear chimeric compounds, polynucleotides, uses and methods for preparation thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 28 patents shown.
Pro members see all 28.
Pro members: see all 28 patents
Also on record, not counted in the 28: 2 patents in force now held by others · 21 lapsed for an unpaid fee · 17 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 5 abandoned · 8 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited